Dechert advised Antios Therapeutics on the deal. Antios Therapeutics, Inc. (“Antios”) completed its $96 million Series B financing. Antios is a clinical-stage biopharmaceutical company focused on the...
Antios Therapeutics’ $96 Million Series B Financing
Solaris Yachts’ Acquisition of CNB Yachts
Bird & Bird advised Solaris Yachts, while Dechert advised Beneteau Group on the deal. Solaris Yachts executed the acquisition from Bénéteau S.A. and its subsidiary Construction Navale...
Two Lebanese American Citizens v. Banque du Liban
Dechert secured a significant win for client Banque du Liban (BDL), Lebanon’s central bank, on the case. On April 9, 2021, Judge Denise Cote of the...
Two Lebanese American Citizens v. Banque du Liban
Dechert secured a significant win for client Banque du Liban (BDL), Lebanon’s central bank, on the case. On April 9, 2021, Judge Denise Cote of the...
Filippo Monteleone and Domnin de Kerdaniel’s Acquisition of Essling Capital
Scotto Partners and Dechert advised Filippo Monteleone and Domnin de Kerdaniel on the deal. Domnin de KERDANIEL (CVC Capital Partners, 3i, KKR) and Filippo MONTELEONE, Founding...
Onward Therapeutics Acquisition of Minority Stakes in Biomunex and EMERCell
IN BRIEF: Dechert, PMLC Avocats, advised on the matter. Dechert advised Biomunex Pharmaceuticals with a team including Anne-Charlotte Rivi?e (Picture – Corporate M&A). PMLC Avocats advised...
National Dentex Labs’ Acquisition of Dental Services Group
Dechert advised National Dentex Labs on the deal. National Dentex Labs (NDX), a portfolio company of funds affiliated with Cerberus Capital Management, L.P. (“Cerberus”), executed acquisition...
Royalty Pharmaìs Acquisition of Royalty Interest from GSK
Dechert advised Royalty Pharma on the deal. Royalty Pharma plc executed its acquisition of a royalty interest in the cabozantinib products Cabometyx and Cometriq from GlaxoSmithKline...
Horizon Technology Finance Management’s Strategic Partnership With Waterfall Asset Management
Dechert advised Horizon Technology Finance Management LLC on the deal. Horizon Technology Finance Management LLC (“Horizon”) closed its agreement with Waterfall Asset Management to originate and...
SK and Geely Automobile’s Launch of New Mobility Investment Fund
Dechert, working alongside Maples and Calder, acted as counsel to SK Inc. for the deal. SK Inc. (formerly SK Holdings) (“SK Inc.”) completed its joint launch...
IQVIA’s $760 Million Acquisition of Q2 Solutions
Dechert advised Quest Diagnostics in the transaction. Quest Diagnostics completed the sale of its ownership interest in Q2 Solutions, a global leader in central laboratory services...
Olgram’s €1,5 Million Funding
Dechert advised Olgram on the deal. Olgram, a French biotech company that develops algae-based anti-infectives, completed its €1.5 million fundraising. The investors include bpifrance, the Brittany...